If you supply, mold, machine, assemble, or package for a medical device OEM, chances are at least one of your competitors has changed ownership recently — but what does it mean for you?

In this session, you’ll learn about who is doing that buying and why. Strategics, hybrids and private equity are moving decisively in the medtech supply chain, and the outsourcing base looks materially different than it did a few years ago. We’ll lay out the shape of that consolidation, what’s driving it, and what it looks like from where you sit. MedWorld Advisors works internationally with founders and business owners on the sell side of these types of transactions, representing the companies being acquired.

Register today for this webinar where MedWorld Advisors covers why stakeholders of certain CDMOs obtain higher valuations than other medtech suppliers. Find out about the changing industry dynamics as you are competing against consolidated, well-capitalized platforms. If you’re still independent, learn why a post-COVID, post-tariff supply chain has turned valuation into a global rather than a domestic conversation.